Side-by-side comparison of AI visibility scores, market position, and capabilities
Descope provides a no-code authentication flow builder combined with authentication SDKs, enabling product teams and developers to collaborate on login experiences.
Descope is an authentication and user management platform founded in 2022 by former Palo Alto Networks executives, raising $53M in seed funding. The company differentiates from developer-only auth tools by providing a visual flow builder that allows product managers and designers to create and modify authentication flows without engineering changes, alongside developer SDKs for full code-level control. This enables faster iteration on login experiences since non-technical team members can run A/B tests on onboarding flows, add new auth methods, or modify password requirements without deploying code. Descope supports magic links, passwords, biometrics, social login, SAML SSO, TOTP, and passkeys. The platform includes user management, session management, and risk-based authentication that adapts security requirements based on contextual signals. Descope serves SaaS companies across B2C and B2B segments that want to move faster on authentication improvements without consuming engineering capacity, and competes with Auth0, Cognito, and Firebase Authentication in the managed authentication service market.
a2z Radiology AI raised $20M in 2025 for its whole-body AI that simultaneously screens for 24+ conditions across CT scans — from incidental cancers to cardiovascular risk — in a single automated read.
a2z Radiology AI has developed a whole-body CT analysis platform that simultaneously screens for over 24 medical conditions across a single CT scan, including incidental cancers, coronary artery disease, aortic aneurysm, bone density loss, and organ abnormalities. The AI acts as a second reader that radiologists can use to catch incidental findings that fall outside the primary reason for a scan — a major source of missed diagnoses.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.